The anchor tranche included participation from main world institutional traders together with GIC, Constancy, BlackRock, Morgan Stanley Funding Administration (Counterpoint World), Goldman Sachs Asset Administration and WCM Funding Administration together with largest home mutual funds like SBI Mutual Fund, Axis Mutual Fund and Birla Mutual Fund. The allocation additionally went to globally distinguished technology-focused traders similar to Dragoneer Funding Group.
The anchor e book noticed demand exceeding Rs 80,000 crore, translating to just about 30 occasions oversubscription.
Earlier at present an argument erupted with ET reporting a setback within the anchor e book. The report stated that a number of main traders pulled out when the Indian e-commerce agency was stated to have allotted a couple of quarter of the shares on this tranche to SBI Funds Administration Pvt.
Additionally Learn: Meesho faces investor protest over anchor allotment to SBI Funds
Among the many SBI funds that acquired allocations have been The SBI Revolutionary Alternatives Fund, SBI Consumption Alternatives Fund, SBI Resurgent India Alternatives Scheme.
Meesho IPO GMP
The Meesho IPO is producing vital buzz within the gray market, with its gray market premium (GMP) hovering round Rs 50-51, hours earlier than its opening. This interprets to an anticipated itemizing acquire of practically 46% at Rs 162.
A gray market premium (GMP) displays the unofficial value at which IPO shares are being traded amongst traders earlier than itemizing. Although not regulated by exchanges, GMP presents a market-based indicator of potential demand and pricing expectations.
A powerful GMP typically suggests sturdy investor curiosity and the potential of a constructive itemizing, though it’s not a assure of efficiency.
Meesho IPO particulars and key dates
The Meesho IPO will open for subscription from December 3 to December 5, with the value band mounted at Rs 105–Rs 111 per fairness share. The lot dimension for retail traders is 135 shares, amounting to a complete funding of Rs 14,985 per lot on the higher value band.
Allotment is anticipated to be finalized by December 8, adopted by refunds and demat credit on December 9. Itemizing is scheduled for December 10, on the mainboard exchanges.
What analysts say about Meesho IPO?
Based on analysts, Meesho has carved a robust place in India’s value-focused e-commerce house, backed by bettering unit economics, rising person engagement, and an increasing vendor base.
Whereas the corporate’s near-term profitability stays below stress as a result of restructuring and operational prices, its implied FY25 price-to-sales ratio of 5.5x is seen as affordable in comparison with friends.
Perumal Raja Okay. J. of FundsIndia believes Meesho presents a medium-term alternative for traders who’re snug with early-stage platform dangers.
India’s e-commerce sector itself is projected to develop quickly, with the retail market anticipated to increase from Rs 83 lakh crore to Rs 135 lakh crore by FY30. Non-electronics penetration stays low, providing appreciable headroom for Meesho to scale.
About Meesho and financials
Meesho reported sturdy progress in FY25, with income rising from Rs 5,730 crore in FY23 to Rs 9,390 crore, pushed by increased order volumes, improved vendor companies, and higher fulfilment effectivity. Regardless of momentary losses in Q1 FY26 as a result of restructuring and ESOP bills, the corporate reported constructive free money circulate for each FY24 and FY25.
Person engagement additionally surged, with annual transacting customers reaching 234.2 million as of September 2025, up from 175 million a 12 months earlier. Order volumes elevated to 1,261 million, whereas the variety of energetic sellers rose to 706,471.
Lead managers for Meesho IPO
The IPO is being managed by a consortium of high funding banks, together with Kotak Mahindra Capital, J.P. Morgan, Morgan Stanley, Axis Capital, and Citigroup. KFin Applied sciences is serving because the registrar to the problem.
Buying and selling is anticipated to start on December 10, pending regulatory approvals.
(Disclaimer: Suggestions, ideas, views and opinions given by the specialists are their very own. These don’t signify the views of The Financial Instances)